Contribute Try STAT+ Today

As litigation proceeds over the Zantac heartburn pill and a possible carcinogen, a court filing contends that Sanofi (SNY) destroyed countless employee emails tied to the 2019 recall of the widely used medicine.

The “widespread destruction” has delayed the proceedings and could make it more difficult for consumers to prove Sanofi and other manufacturers knew their medicines could produce high levels of NDMA over time, according to a document filed by lawyers who represent more than 70,000 people who filed claims in federal court.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.